½ÃÀ庸°í¼­
»óǰÄÚµå
1552509

¼¼°èÀÇ DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦°ø ¼­ºñ½º À¯Çüº°, À¯ÀüÀÚ À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚ »ê¾÷º°, Áö¿ªº° ½ÃÀå ¿¹Ãø(2024-2032³â)

DNA and Gene Cloning Services Market Size, Share, Trends, Industry Analysis Report: By Type of Service Offered, Type of Gene, End-User Industry, and By Region - Market Forecast, 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 119 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃÖ±Ù Á¶»ç¿¡ µû¸£¸é ¼¼°è DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 82¾ï 162¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ¼¼°è ½ÃÀåÀº À¯ÀüÀÚ ¿¬±¸¿Í »ý¸í°øÇÐÀÇ Áøº¸¿¡ ÈûÀÔ¾î ´ëÆøÀûÀÎ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº À¯ÀüÀÚ ÇÕ¼º, ¼­ºêŬ·Î´×, µ¹¿¬º¯ÀÌÀ¯¹ß, º¤ÅÍ ±¸Ãà µî ´Ù¾çÇÑ ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖÀ¸¸ç, Çмú±â°ü, Á¦¾àȸ»ç, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷¿¡ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í À¯Àü¼º ÁúȯÀÇ ¹ß»ý·ü Áõ°¡ µîÀÌ ÀÖÀ¸¸ç, ¸ðµÎ °í±Þ ¿¬±¸ ¹× Ä¡·á ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù. °Ô´Ù°¡ Áß¿äÇÑ µ¿ÇâÀ¸·Î¼­ Á¤È®ÇÑ À¯ÀüÀÚ ÆíÁýÀ» À§ÇÑ CRISPR ±â¼úÀÇ Ã¤¿ë°ú ÇÕ¼º »ý¹°ÇÐ ÀÀ¿ëÀÇ È®´ë°¡ ÀÖÀ¸¸ç, ÀÌµé ¸ðµÎ´Â ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÌ¿ë °¡´ÉÇÑ Å¬·Î´× ¼­ºñ½ºÀÇ ¹üÀ§¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù.

DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå °æÀï ±¸µµÀº Ä¡¿­ÇÑ °æÀï°ú Áö¼ÓÀûÀÎ Çõ½ÅÀ» Ư¡À¸·Î ÇÕ´Ï´Ù. Thermo Fisher Scientific°ú GenScript´Â ±¤¹üÀ§ÇÑ ¼­ºñ½º Æ÷Æ®Æú¸®¿À¿Í ¼¼°èÀÇ Á¸Àç·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù.

DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ® :

Á¦°ø ¼­ºñ½º À¯ÇüÀ» ±â¹ÝÀ¸·Î, À¯ÀüÀÚ ÇÕ¼º ºÎ¹®Àº ´Ù¾çÇÑ À¯ÀüÀÚ ¿¬±¸ ¹× »ý¸í °øÇÐ ¾ÖÇø®ÄÉÀ̼ÇÀ» È«º¸ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»Çϱâ À§ÇØ 2023³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.

À¯ÀüÀÚ À¯Çüº°·Î, ·çƾÀÇ À¯ÀüÀÚ ¿¬±¸, Áø´Ü ¹× ½ÃÀå °³Ã´¿¡ ³Î¸® ÀÀ¿ëµÇ°í Àֱ⠶§¹®¿¡ Ç¥ÁØ À¯ÀüÀÚ ºÎ¹®ÀÌ 2023³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.

Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ ºÎ¹®ÀÌ 2023³â ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷Àº â¾à, À¯ÀüÀÚ Ä¡·á °³¹ß, ¹ÙÀÌ¿À ÀǾàǰ »ý»êÀ» À§ÇØ º¹Á¦ ¼­ºñ½º¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. Á¤È®ÇÑ À¯ÀüÀÚ º¯ÇüÀÇ Çʿ伺°ú ½Å±Ô Ä¡·á ¼Ö·ç¼ÇÀÇ °³¹ßÀÌ ÀÌ ºÎ¹®¿¡¼­ DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â ½ÃÀåÀ» µ¶Á¡ÇÏ°í ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¾ïÁ¦¿äÀΰú °úÁ¦
  • PESTEL ºÐ¼®
  • DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå : Á¦°ø ¼­ºñ½º À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • À¯ÀüÀÚ ÇÕ¼º
  • Ä¿½ºÅÒ Å¬·Ð
  • ¼­ºê Ŭ·Î´×
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå : À¯ÀüÀÚ À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • Ç¥ÁØ À¯ÀüÀÚ
  • º¹ÇÕ À¯ÀüÀÚ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚ »ê¾÷º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • Çмú°ú ¿¬±¸¡¤°³¹ß
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå :Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • DNA ¹× À¯ÀüÀÚ Å¬·Î´× ¼­ºñ½º ½ÃÀå Æò°¡:Áö¿ªº°, 2019-2032³â
  • ºÏ¹Ì
    • ºÏ¹Ì : Á¦°ø ¼­ºñ½º À¯Çüº°, 2019-2032³â
    • ºÏ¹Ì : À¯ÀüÀÚ À¯Çüº°, 2019-2032³â
    • ºÏ¹Ì : ÃÖÁ¾»ç¿ëÀÚ »ê¾÷º°, 2019-2032³â
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : Á¦°ø ¼­ºñ½º À¯Çüº°, 2019-2032³â
    • À¯·´ : À¯ÀüÀÚ À¯Çüº°, 2019-2032³â
    • À¯·´ : ÃÖÁ¾»ç¿ëÀÚ »ê¾÷º°, 2019-2032³â
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç: Á¦°ø ¼­ºñ½º À¯Çüº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç: À¯ÀüÀÚ À¯Çüº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç: ÃÖÁ¾ »ç¿ëÀÚ »ê¾÷º°, 2019-2032³â
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«: Á¦°ø ¼­ºñ½º À¯Çüº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«: À¯ÀüÀÚ À¯Çüº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾»ç¿ëÀÚ »ê¾÷º°, 2019-2032³â
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«: Á¦°ø ¼­ºñ½º À¯Çüº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : À¯ÀüÀÚ À¯Çüº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾»ç¿ëÀÚ »ê¾÷º°, 2019-2032³â
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Thermo Fisher Scientific
  • GenScript
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Merck KGaA
  • Takara Bio
  • New England Biolabs
  • Lonza Group
  • Integrated DNA Technologies
  • Origene Technologies
  • Creative Biogene
  • Genewiz
  • Addgene
  • Eurofins Scientific
  • Twist Bioscience
JHS 24.10.10

The global DNA and gene cloning services market size is expected to reach USD 8,201.62 million by 2032, according to a new study by Polaris Market Research. The report "Global DNA and Gene Cloning Services Market Size, Share, Trends, Industry Analysis Report: By Type of Service Offered (Gene Synthesis, Custom Cloning, Sub-cloning, and Others), By Type of Gene, End-User Industry, and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global market for DNA and gene cloning services is witnessing substantial growth, fueled by advances in genetic research and biotechnology. The market offers a variety of services such as gene synthesis, subcloning, mutagenesis, and vector construction, serving academic institutions, pharmaceutical companies, and biotech firms. Key drivers include the rising demand for personalized medicine and the increasing incidence of genetic disorders, both of which require sophisticated research and treatment solutions. Additionally, significant trends include the adoption of CRISPR technology for accurate gene editing and the expansion of synthetic biology applications, both of which are driving innovation and enhancing the range of available cloning services.

The competitive landscape of the DNA and gene cloning services market is characterized by intense competition and continuous innovation. Thermo Fisher Scientific and GenScript lead the market with extensive service portfolios and strong global presence.

DNA and Gene Cloning Services Market Report Highlights:

Based on type of service offered, the gene synthesis segment dominated the market in 2023 due to its critical role in facilitating various genetic research and biotechnological applications.

By type of gene, the standard genes segment dominated the market in 2023 due to their widespread application in routine genetic research, diagnostics, and therapeutic developments.

The pharmaceutical and biotechnology companies' segment held the largest market share in 2023. These companies rely heavily on cloning services for drug discovery, gene therapy development, and biopharmaceutical production. The need for precise genetic modifications and the development of novel therapeutic solutions propel the demand for DNA and gene cloning services in this segment.

North America dominates the market, whereas Asia-Pacific is expected to witness the highest growth rate.

Polaris Market Research has segmented the DNA And Gene Cloning Services market report

DNA and Gene Cloning Services, Type of Service Outlook (Revenue - USD million, 2019-2032)

  • Gene Synthesis
  • Custom Cloning
  • Sub-cloning
  • Others

DNA and Gene Cloning Services, Type of Gene Outlook (Revenue - USD million, 2019-2032)

  • Standard Gene
  • Complex Gene
  • Others

DNA and Gene Cloning Services, End-User Industry Outlook (Revenue - USD million, 2019-2032)

  • Academic and R&D
  • Pharmaceutical and Biotechnology Companies
  • Others

DNA and Gene Cloning Services, Regional Outlook (Revenue - USD million, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global DNA and Gene Cloning Services Market Insights

  • 4.1. DNA and Gene Cloning Services Market - Market Snapshot
  • 4.2. DNA and Gene Cloning Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Integration of CRISPR Technology
      • 4.2.1.2. Expansion of Synthetic Biology End-User Industrys
      • 4.2.1.3. Increasing Demand for Personalized Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Technical Complexity is Hindering the Market Growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. DNA and Gene Cloning Services Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global DNA and Gene Cloning Services Market, by Type of Service Offered

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
  • 5.3. Gene Synthesis
    • 5.3.1. Global DNA and Gene Cloning Services Market, by Gene Synthesis, by Region, 2019-2032 (USD million)
  • 5.4. Custom Cloning
    • 5.4.1. Global DNA and Gene Cloning Services Market, by Custom Cloning, by Region, 2019-2032 (USD million)
  • 5.5. Sub-cloning
    • 5.5.1. Global DNA and Gene Cloning Services Market, by Sub-cloning, by Region, 2019-2032 (USD million)
  • 5.6. Others
    • 5.6.1. Global DNA and Gene Cloning Services Market, by Others, by Region, 2019-2032 (USD million)

6. Global DNA and Gene Cloning Services Market, by Gene Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
  • 6.3. Standard Gene
    • 6.3.1. Global DNA and Gene Cloning Services Market, by Standard Gene, by Region, 2019-2032 (USD million)
  • 6.4. Complex Gene
    • 6.4.1. Global DNA and Gene Cloning Services Market, by Complex Gene, by Region, 2019-2032 (USD million)
  • 6.5. Others
    • 6.5.1. Global DNA and Gene Cloning Services Market, by Others, by Region, 2019-2032 (USD million)

7. Global DNA and Gene Cloning Services Market, by End-User Industry

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
  • 7.3. Academic and R&D
    • 7.3.1. Global DNA and Gene Cloning Services Market, by Academic and R&D, by Region, 2019-2032 (USD million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. Global DNA and Gene Cloning Services Market, by Pharmaceutical and Biotechnology Companies, by Region, 2019-2032 (USD million)
  • 7.5. Others
    • 7.5.1. Global DNA and Gene Cloning Services Market, by Others, by Region, 2019-2032 (USD million)

8. Global DNA and Gene Cloning Services Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. DNA and Gene Cloning Services Market Assessment, By Geography, 2019-2032 (USD million)
  • 8.3. DNA and Gene Cloning Services Market - North America
    • 8.3.1. North America: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
    • 8.3.2. North America: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
    • 8.3.3. North America: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.3.4. DNA and Gene Cloning Services Market - U.S.
      • 8.3.4.1. U.S.: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.3.4.2. U.S.: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.3.4.3. U.S.: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.3.5. DNA and Gene Cloning Services Market - Canada
      • 8.3.5.1. Canada: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.3.5.2. Canada: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.3.5.3. Canada: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
  • 8.4. DNA and Gene Cloning Services Market - Europe
    • 8.4.1. Europe: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
    • 8.4.2. Europe: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
    • 8.4.3. Europe: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.4. DNA and Gene Cloning Services Market - UK
      • 8.4.4.1. UK: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.4.2. UK: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.4.3. UK: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.5. DNA and Gene Cloning Services Market - France
      • 8.4.5.1. France: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.5.2. France: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.5.3. France: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.6. DNA and Gene Cloning Services Market - Germany
      • 8.4.6.1. Germany: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.6.2. Germany: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.6.3. Germany: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.7. DNA and Gene Cloning Services Market - Italy
      • 8.4.7.1. Italy: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.7.2. Italy: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.7.3. Italy: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.8. DNA and Gene Cloning Services Market - Spain
      • 8.4.8.1. Spain: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.8.2. Spain: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.8.3. Spain: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.9. DNA and Gene Cloning Services Market - Netherlands
      • 8.4.9.1. Netherlands: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.9.2. Netherlands: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.9.3. Netherlands: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.10. DNA and Gene Cloning Services Market - Russia
      • 8.4.10.1. Russia: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.10.2. Russia: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.10.3. Russia: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.11. DNA and Gene Cloning Services Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.11.2. Rest of Europe: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.11.3. Rest of Europe: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
  • 8.5. DNA and Gene Cloning Services Market - Asia Pacific
    • 8.5.1. Asia Pacific: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
    • 8.5.2. Asia Pacific: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
    • 8.5.3. Asia Pacific: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.4. DNA and Gene Cloning Services Market - China
      • 8.5.4.1. China: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.4.2. China: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.4.3. China: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.5. DNA and Gene Cloning Services Market - India
      • 8.5.5.1. India: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.5.2. India: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.5.3. India: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.6. DNA and Gene Cloning Services Market - Malaysia
      • 8.5.6.1. Malaysia: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.6.2. Malaysia: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.6.3. Malaysia: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.7. DNA and Gene Cloning Services Market - Japan
      • 8.5.7.1. Japan: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.7.2. Japan: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.7.3. Japan: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.8. DNA and Gene Cloning Services Market - Indonesia
      • 8.5.8.1. Indonesia: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.8.2. Indonesia: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.8.3. Indonesia: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.9. DNA and Gene Cloning Services Market - South Korea
      • 8.5.9.1. South Korea: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.9.2. South Korea: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.9.3. South Korea: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.10. DNA and Gene Cloning Services Market - Australia
      • 8.5.10.1. Australia: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.10.2. Australia: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.10.3. Australia: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.11. DNA and Gene Cloning Services Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.11.2. Rest of Asia Pacific: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.11.3. Rest of Asia Pacific: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
  • 8.6. DNA and Gene Cloning Services Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
    • 8.6.2. Middle East & Africa: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
    • 8.6.3. Middle East & Africa: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.6.4. DNA and Gene Cloning Services Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.6.4.2. Saudi Arabia: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.6.4.3. Saudi Arabia: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.6.5. DNA and Gene Cloning Services Market - UAE
      • 8.6.5.1. UAE: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.6.5.2. UAE: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.6.5.3. UAE: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.6.6. DNA and Gene Cloning Services Market - Israel
      • 8.6.6.1. Israel: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.6.6.2. Israel: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.6.6.3. Israel: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.6.7. DNA and Gene Cloning Services Market - South Africa
      • 8.6.7.1. South Africa: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.6.7.2. South Africa: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.6.7.3. South Africa: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.6.8. DNA and Gene Cloning Services Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.6.8.2. Rest of Middle East & Africa: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.6.8.3. Rest of Middle East & Africa: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
  • 8.7. DNA and Gene Cloning Services Market - Latin America
    • 8.7.1. Latin America: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
    • 8.7.2. Latin America: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
    • 8.7.3. Latin America: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.7.4. DNA and Gene Cloning Services Market - Mexico
      • 8.7.4.1. Mexico: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.7.4.2. Mexico: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.7.4.3. Mexico: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.7.5. DNA and Gene Cloning Services Market - Brazil
      • 8.7.5.1. Brazil: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.7.5.2. Brazil: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.7.5.3. Brazil: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.7.6. DNA and Gene Cloning Services Market - Argentina
      • 8.7.6.1. Argentina: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.7.6.2. Argentina: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.7.6.3. Argentina: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.7.7. DNA and Gene Cloning Services Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.7.7.2. Rest of Latin America: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.7.7.3. Rest of Latin America: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Thermo Fisher Scientific
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. GenScript
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Agilent Technologies
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bio-Rad Laboratories
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Merck KGaA
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Takara Bio
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. New England Biolabs
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Lonza Group
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Integrated DNA Technologies
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Origene Technologies
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Creative Biogene
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Genewiz
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Addgene
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Eurofins Scientific
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Twist Bioscience
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦